Brief: Arch Biopartners Obtains DTC Eligibility For Its Common Shares On OTCQB
21/08/2020 13:08
Aug 21 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS OBTAINS DTC ELIGIBILITY FOR ITS COMMON
SHARES
ON OTCQB
Source text for Eikon: ID:nGNX6r2spd
Further company coverage: ARCH.V
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide